Pharm Exec speaks with Spanish-born Belén Garijo, CEO of Merck KGaA, Darmstadt, Germany’s healthcare business, who shares her steady-eyed approach in transforming a traditional pharma unit focused on small molecules for chronic disease to a high-tech specialty producer of immunotherapy drugs for rare cancers.
Sponsored Content
Anthony Arnold offers an overview and update of bioelectronic medicine.
Pharmaceutical Executive
Pharm Exec sits down with veteran journalist Paula Apsell, the driving force behind the long-running PBS science series NOVA. Apsell offers straightforward advice to the biopharma industry: make your business a business of inspiration, where the return is measured in passion-and the sheer, simple pleasure of finding things out.
Pharmaceutical Executive
The FDA’s Dr. John Whyte offers his perspectives on patient centricity and the issues that FDA and industry are facing.
Highlights from Peter Young's conversation with Dr. Steven Miller, Chief Medical Officer and SVP of Express Scripts, on Miller's business philosophy and the current issues facing the sector.
Pharmaceutical Executive
Pharm Exec sits down with Jeremy Desai, CEO of Apotex, Canada’s largest producer of generic drugs, to discuss the local impact of mounting pricing pressure-and how smaller and independent companies can survive in an era of consolidation and growing competition.
Founder and CEO, Bloodbuy
President, Global Vaccines, Merck & Co.
Senior Director, Consumer Scientific Innovation, Johnson & Johnson Innovation
Vice President and Head, Innovation Center, Global Health and Value, Pfizer Inc.
President, US Pharmaceuticals, Bayer
Senior Director of Sales Analytics and Operations, Gilead Sciences
Vice President, Business and Financial Planning, Merck & Co.
Vice President, US Payer & Institutional Strategy Lead, Shire
Pharmaceutical Executive
Pharm Exec’s 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable-or complacent.
Global Head, Drug Development, and Chief Medical Officer, Novartis
Vice President, Business Development, Regeneron Pharmaceuticals
Co-Founders, twoXAR
Vice President, Business Technology, Pfizer Inc.
Pharmaceutical Executive
Pharm Exec sits down with UBC President Patrick Lindsay to provide some real-world context around our 2016 feature profile of sixteen Emerging Leaders in biopharma.
Vice President, Psychiatry Marketing, Lundbeck US
Senior Director, Marketing, XenoPort
Managing Director, Singapore and Asian Emerging Markets, Novartis
Pharm Exec sits down with Anthony Marucci, co-founder and CEO of Celldex, a stealth player in the immunotherapy field.
Envigo's new CEO shares with Pharm Exec his vision for the company’s future, the changes he’s seen in the industry, and his thoughts on that thorny subject, Brexit.
